Concepedia

Yuki Mukai

YM

Statistics

Publications

23

Citations

1.8K

H-Index

15

Active since

2002

Affiliations

Yokohama City University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Lou Ruvo Brain Institute

Inserm

University of Southern California

Yuki Mukai is an author at Yokohama City University specializing in medicine, radiation oncology, and radiation therapy.

ORCID

Top concepts

Publications per year

2002–2024

23

Publications

23

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

Michael Egan, James Kost, Pierre N. Tariot et al. · New England Journal of Medicine · 2018 · 650 citations · Full text

Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

Michael Egan, James Kost, Tiffini Voss et al. · New England Journal of Medicine · 2019 · 535 citations · Full text

Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease

Alette M. Wessels, Christopher Lines, Robert A. Stern et al. · Alzheimer s & Dementia · 2020 · 88 citations

Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease

Michael Egan, Yuki Mukai, Tiffini Voss et al. · Alzheimer s Research & Therapy · 2019 · 75 citations · Full text

BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer’s disease brain

Cyrille Sur, James Kost, David Scott et al. · Brain · 2020 · 73 citations · Full text

, , +22

1–5 of 23